A rare but serious side effect of levofloxacin [10]

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1716-1717

  Kanbay, Mehmet ^a,b   Aydogan, Timucin ^a   Bozalan, Rifat ^a   Isik, Ayse ^a   Burak, U ^a   Kaya, Arif ^a   Akcay, Ali ^a  

^a FATIH UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINAFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; OMEPRAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ADULT; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DIET THERAPY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPOGLYCEMIA; LABORATORY TEST; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; MIDDLE AGED; OFLOXACIN; PNEUMONIA; URINARY TRACT INFECTIONS;

EID: 33746402473     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0788     Document Type: Letter

References (7)

1. Brogan ES, Chalan MK: Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesth Analg 101:635-636, 2005
2. Friedrich LV, Dougherty R: Fatal hypoglycemia associated with levofloxacin. Pharmacotherapy 24:1807-1812, 2004
3. Norrby SR, Lietman PS: Safety and tolerability of fluoroquinolones. Drugs 45 (Suppl. 3):59-64, 1993
4. Whiteley MS, Worlding J, Patel S, Gibbs KB: Hypoglycemia in a diabetic patient, associated with ciprofloxacin therapy. Pract Diabetes 10:35, 1999
5. Welling L, Burke CL: Safety of clinafloxacin (CLX), a new fluoroquinolone antibiotic. Presented at the 39th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 26-29 September 1999.
6. Saraya A, Yokokura M, Gonoi T, Seino S: Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels. Eur J Pharmacol 497:111-117, 2004
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245, 1981